Nuzenio

Cmpx Aug

Cmpx Aug news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 3 publisher sources 100/100 entity strength

Latest news

We're Not Very Worried About Compass Therapeutics' (NASDAQ:CMPX) Cash Burn Rate - simplywall.stsimplywall.st · Sat, 08 Aug 2026 13:04:42 GMTCompass Therapeutics, Inc. Stock 12‑Month Price Target Raised to $8.67, Implies 359% Upside - TradingViewTradingView · Thu, 06 Aug 2026 23:20:13 GMTCompass Therapeutics, Inc. 2026: Revenue ($25.25M), Net income ($25.15M), EPS ($0.13) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 12:11:09 GMTCMPX: Q2 2026 net loss widened to $25.2M as R&D and G&A costs rose; cash runway extends into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 12:03:09 GMTCompass Therapeut reports Q2 2026 net loss $25.2M, $180M cash runway into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 11:33:01 GMTCMPX: Strong pipeline progress and solid cash position support continued clinical development - TradingViewTradingView · Thu, 06 Aug 2026 11:32:04 GMTCMPX Aug 2026 4.000 put (CMPX260821P00004000) interactive stock chart - Yahoo Finance UKYahoo Finance UK · Tue, 04 Aug 2026 16:35:42 GMTCMPX Aug 2026 13.000 call (CMPX260821C00013000) interactive stock chart - Yahoo Finance UKYahoo Finance UK · Tue, 04 Aug 2026 00:14:00 GMT

Timeline

Sat, 08 Aug 2026 13:04:42 GMTWe're Not Very Worried About Compass Therapeutics' (NASDAQ:CMPX) Cash Burn Rate - simplywall.st
Thu, 06 Aug 2026 23:20:13 GMTCompass Therapeutics, Inc. Stock 12‑Month Price Target Raised to $8.67, Implies 359% Upside - TradingView
Thu, 06 Aug 2026 12:11:09 GMTCompass Therapeutics, Inc. 2026: Revenue ($25.25M), Net income ($25.15M), EPS ($0.13) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 12:03:09 GMTCMPX: Q2 2026 net loss widened to $25.2M as R&D and G&A costs rose; cash runway extends into 2028 - TradingView
Thu, 06 Aug 2026 11:33:01 GMTCompass Therapeut reports Q2 2026 net loss $25.2M, $180M cash runway into 2028 - TradingView
Thu, 06 Aug 2026 11:32:04 GMTCMPX: Strong pipeline progress and solid cash position support continued clinical development - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cmpx Aug.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.